Tom Francke

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA.

Seco Tools AB manufactures and supplies carbide cutting tools and associated equipment. It provides metal cutting solutions for milling, stationary tools, hole making and tooling systems. The company was founded in 1932 and is headquartered in Fagersta, Sweden.

Kreos Capital Management (UK) Ltd (Kreos Capital) is a private equity firm founded in 1998. The firm is headquartered in London with additional offices in Israel, Sweden, Jersey and Luxembourg.

Toyota Industries Sweden AB operates as a holding company. It manages over 90 subsidiaries worldwide. The company engages in manufacturing electric and manual lift trucks which are used in material handling with in companies and warehouses. Toyota Industries Sweden was founded in 1946 and is located in Linkoping, Sweden

Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France.

Linköping University Hospital provides healthcare services.

DIAB has been at the leading edge of composite core material development for over fifty years. In particular it has pioneered the use of the sandwich concept to make structures that are significantly lighter and stronger than those made from steel, aluminum and wood. The company has also been very much the technology leader in its field. DIAB was instrumental in introducing core kits to enable its customers to speed their fabrication processes, improve quality, reduce inventory levels and cut waste. It has also been in the vanguard of new environment-friendly processing developments such as DIAB Core Infusion™. DIAB is one of world's largest manufacturers of structural core materials supplying a wide range of markets including marine, wind energy, transportation, aerospace and industry. DIAB has manufacturing facilities on four continents and three research and development centers. In addition it has seventeen operating subsidiaries and strategically located distributors around the world so that it can offer close support to its global customer base. The company has always been much more than just a materials supplier. To this end DIAB endeavors to establish long-term partnerships with its customers by not only supplying high performance materials but also providing an extensive range of technical support services that include process development, structural design and training.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom.

Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.

Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France.

Part of ULURU, Inc., ULURU Delaware, Inc. develops drug delivery systems. The company is based in Virginia Beach, VA. The CEO of the company is R. Stephen Stagner.

Hultdin System AB manufactures and trades equipment and installation components for the forestry and construction sectors. Its products include grapples, chain saw systems, and rotators for heavy equipment. The company was founded by Waldemar Hultdin in 1928 and is headquartered in Malå, Sweden.

Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands.

Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain.

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

Kage Gjutmek AB is an iron foundry located in Kage, Sweden. The Swedish company specializes in producing prototypes and small series of gray iron, shirts, and compact graphite iron directly from customer drawings or finished castings.

HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

iBionext SAS (iBionext) is an independent venture capital firm headquartered in Paris, France. The firm was founded in 2012 by Christophe Bancel and Alexia Perouse.

Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France.

Chronolife SAS engages in the research and development activity in natural sciences. The company is headquartered in Paris, France.

Tilak Healthcare SAS develops platform of serious medical games. It enables diagnostic and therapy of ophthalmologic diseases through early detection and self-tracking. The company was founded in 2016 and is headquartered in Paris, France.

Cyann Holding functions as an investment holding French company.

Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland.

T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany.